Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity

被引：3
作者：
Choi, Sung Hee [1 ,2 ]
Myers, Jay Thomas [1 ]
Tomchuck, Suzanne Louise [1 ]
Bonner, Melissa [3 ]
Eid, Saada [1 ]
Kingsley, Daniel Tyler [3 ]
Vanheyst, Kristen Ashley [1 ,2 ]
Kim, Seong-Jin [4 ]
Kim, Byung-Gyu [1 ,2 ]
Huang, Alex Yee-Chen [1 ,2 ,3 ,5 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH USA
[2] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH USA
[4] MedPacto Inc, Seoul, South Korea
[5] Rainbow Babies & Childrens Hosp, Angie Fowler AYA Canc Inst, Ctr Pediat Immunotherapy, Cleveland, OH USA
来源：
CANCER COMMUNICATIONS | 2024年 / 44卷 / 08期
关键词：
D O I：
10.1002/cac2.12589
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：884 / 888
页数：5
相关论文
共 50 条
  • [31] Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population
    Hu, Yun-Sheng
    Pan, Yong
    Li, Wen-Hai
    Zhang, Yong
    Li, Jun
    Ma, Bao-An
    MEDICAL ONCOLOGY, 2011, 28 (02) : 622 - 625
  • [32] TRANSFORMING GROWTH FACTOR-ALPHA AND FACTOR-BETA ARE POTENT AND EFFECTIVE INHIBITORS OF GH4 PITUITARY-TUMOR CELL-PROLIFERATION
    RAMSDELL, JS
    ENDOCRINOLOGY, 1991, 128 (04) : 1981 - 1990
  • [33] Soluble Endoglin, Transforming Growth Factor-Beta 1 and Soluble Tumor Necrosis Factor Alpha Receptors in Different Clinical Manifestations of Preeclampsia
    Perucci, Luiza O.
    Gomes, Karina B.
    Freitas, Leticia G.
    Godoi, Lara C.
    Alpoim, Patricia N.
    Pinheiro, Melina B.
    Miranda, Aline S.
    Teixeria, Antonio L.
    Dusse, Luci M.
    Sousa, Lirlandia P.
    PLOS ONE, 2014, 9 (05):
  • [34] A next-generation PI3Kδ/γ inhibitor, ZX-101A inhibiting solid tumor growth by enhancing anti-tumor immunity.
    Hao, Xiaolin
    Peng, Zhiyuan
    Guo, Kun
    Li, Ying-Ying
    Kong, Deming
    Yang, Jinfu
    Qin, Xiaoli
    CANCER RESEARCH, 2021, 81 (13)
  • [35] Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity
    Tanaka, Hiroaki
    Shinto, Osamu
    Yashiro, Masakazu
    Yamazoe, Sadaaki
    Iwauchi, Takehiko
    Muguruma, Kazuya
    Kubo, Naoshi
    Ohira, Masaichi
    Hirakawa, Kosei
    ONCOLOGY REPORTS, 2010, 24 (06) : 1637 - 1643
  • [36] Therapeutic targeting of TREM1 with PY159 promotes myeloid cell reprogramming and unleashes anti-tumor immunity
    Mayes, Erin
    Juric, Vladi
    Binnewies, Mikhail
    Canaday, Pamela
    Lee, Tian
    Dash, Subhadra
    Pollack, Joshua L.
    Rudolph, Joshua
    Huang, Vicky
    Du, Xiaoyan
    Jahchan, Nadine
    Ramoth, Asa J.
    Mankikar, Shilpa
    Norng, Manith
    Santamaria, Carlos
    Baker, Kevin P.
    Liang, Linda
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [37] Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity
    Natoli, Marina
    Herzig, Petra
    Pishali Bejestani, Elham
    Buchi, Melanie
    Ritschard, Reto
    Lloyd, G. Kenneth
    Mohanlal, Ramon
    Tonra, James R.
    Huang, Lan
    Heinzelmann, Viola
    Trub, Marta
    Zippelius, Alfred
    Kashyap, Abhishek S.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Expression of an antisense transforming growth factor-beta 1 transgene reduces tumorigenicity of EMT6 mammary tumor cells
    Park, JA
    Wang, E
    Kurt, RA
    Schluter, SF
    Hersh, EM
    Akporiaye, ET
    CANCER GENE THERAPY, 1997, 4 (01) : 42 - 50
  • [39] Incorporation of SKI-G-801, novel AXL inhibitor, with anti-PD-1 inhibitor plus chemotherapy improved anti-tumor activity and survival outcome via enhancing anti-tumor T cell immunity.
    Pyo, Kyoung-Ho
    Lee, Wongeun
    Lee, Hee Kyu
    Kim, Dong Kwon
    Jo, Ha Ni
    Synn, Chun-Bong
    Kim, Jae Hwan
    Byeon, Yeongseon
    Kim, Young Seob
    Ahn, Beung-Chul
    Hong, Min Hee
    Lim, Sun Min
    Cho, Byoung Chul
    Kim, Hye Ryun
    CANCER RESEARCH, 2021, 81 (13)
  • [40] MPZL1 Promotes Lung Adenocarcinoma Progression by Enhancing Tumor Proliferation, Invasion, Migration, and Suppressing Immune Function via Transforming Growth Factor-β1
    Wang, Ansheng
    Fan, Fangtian
    Zang, Chao
    Li, Chao
    Hong, Haining
    Wang, Zuyi
    Gao, Yuan
    Chen, Liwei
    Yu, Xiaofu
    Zhou, Chao
    Zhao, Chengling
    HUMAN GENE THERAPY, 2023, 34 (11-12) : 540 - 553
12345